Peter S. Sever
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 1%
- Lipoproteins and Cardiovascular Health
Papers in
-
- Blood Pressure and Hypertension Studies 11
- Heart Rate Variability and Autonomic Control 6
-
- Neuropeptides and Animal Physiology 9
- Neurotransmitter Receptor Influence on Behavior 8
- Neuroscience and Neuropharmacology Research 6
- Co-authors
- ANTHONY C. KEECH (17 shared papers)Robert Patrick Giugliano (17 shared papers)Marc Steven Sabatine (17 shared papers)Terje Rolf Pedersen (11 shared papers)Michael E Schachter (26 shared papers)Alun D. Hughes (20 shared papers)Scott M. Wasserman (6 shared papers)Armando Lira Pineda (4 shared papers)
- Journals
- Biochemical Society Transactions (8 papers)Journal of Hypertension (8 papers)Circulation (5 papers)The Lancet (5 papers)Journal of Cardiovascular Pharmacology (5 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Peter S. Sever
128 papers receiving 6.6k citations
Peter S. Sever's Hit Papers
Peers
Comparison fields: 5 of 208
- Endocrinology, Diabetes and Metabolism 1.0k
- Surgery 2.5k
- Cardiology and Cardiovascular Medicine 1.2k
- Cancer Research 389
- Cellular and Molecular Neuroscience 462
Countries citing papers authored by Peter S. Sever
This map shows the geographic impact of Peter S. Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Sever more than expected).
Fields of papers citing papers by Peter S. Sever
This network shows the impact of papers produced by Peter S. Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Sever. The network helps show where Peter S. Sever may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter S. Sever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries Hit paper breakdown → | 2018 | 1083 |
| 2 | HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials Hit paper breakdown → | 2014 | 552 |
| 3 | Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial Hit paper breakdown → | 2017 | 545 |
| 4 | Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Hit paper breakdown → | 2017 | 485 |
| 5 | Cognitive Function in a Randomized Trial of Evolocumab Hit paper breakdown → | 2017 | 387 |
| 6 | The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals Hit paper breakdown → | 2016 | 324 |
| 7 | N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects Hit paper breakdown → | 2020 | 201 |
| 8 | 2020 | 144 | |
| 9 | 2018 | 121 | |
| 10 | 2017 | 118 | |
| 11 | 2011 | 97 | |
| 12 | 2019 | 92 | |
| 13 | 2020 | 90 | |
| 14 | 1977 | 89 | |
| 15 | 2020 | 84 | |
| 16 | 1988 | 83 | |
| 17 | 1987 | 79 | |
| 18 | 1994 | 77 | |
| 19 | 2019 | 75 | |
| 20 | 2021 | 71 |
About Peter S. Sever
Peter S. Sever is a scholar working on Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Surgery, Endocrinology, Diabetes and Metabolism and Physiology, having authored 131 papers that have together received 7.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (27 papers), Receptor Mechanisms and Signaling (14 papers), Blood Pressure and Hypertension Studies (11 papers), Nitric Oxide and Endothelin Effects (11 papers), Neuropeptides and Animal Physiology (9 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Heart Rate Variability and Autonomic Control (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Surgery (2.5k citations), Cardiology and Cardiovascular Medicine (1.2k citations), Cancer Research (389 citations) and Cellular and Molecular Neuroscience (462 citations). Peter S. Sever has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include ANTHONY C. KEECH, Robert Patrick Giugliano, Marc Steven Sabatine, Terje Rolf Pedersen, Michael E Schachter, Alun D. Hughes, Scott M. Wasserman, Armando Lira Pineda, Narimon Honarpour and Ioanna Gouni‐Berthold. Their work appears in journals such as Biochemical Society Transactions, Journal of Hypertension, Circulation, The Lancet and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.